Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Posters
(results will display both Free Papers & Poster)
Corneal stromal demarcation line following standard and high intensity collagen cross-linking determined with anterior segment optical coherence tomography
Poster Details
First Author: G.Kymionis GREECE
Co Author(s): K. Tsoulnaras M. Grentzelos P. Argyro D. Liakopoulos N. Tsakalis I. Pallikaris
Abstract Details
Purpose:
To compare the depth of the corneal stromal demarcation line using anterior
segment optical coherence tomography (AS-OCT) after corneal collagen crosslinking
(CXL) for two different treatment protocols (30 minutes with 3mW/cm2 versus 10
minutes with 9mW/cm2).
Setting:
Vardinoyiannion Eye Institute of Crete (VEIC), Faculty of Medicine,
University of Crete, Heraklion, Crete, Greece
Methods:
Sixteen keratoconic patients (21 eyes) were enrolled. All patients
underwent CXL using the same ultraviolet-A(UV-A) irradiation device (CCL-365,
Peschke Meditrade GmbH, Huenenberg, Switzerland). Seven patients (9 eyes) were
treated for 30 minutes with 3mW/cm2 according to the standard Dresden protocol
(group 1) while 9 patients (12 eyes) were treated for 10 minutes (group 2) with
9mW/cm2 of UV-A irradiation intensity. One month postoperatively, corneal stromal
demarcation line was measured by two independent observers using AS-OCT.
Results:
Mean corneal stromal demarcation line depth was 350.78 ± 49.34 μm (256.5
- 410 μm) for group 1 and 288.46 ± 42.37 μm (238.5 - 353.5 μm) for group 2. There
was a statistically significant difference (t-test for unpaired data, p = 0.0058) in the
corneal stromal demarcation line depth between the two groups; corneal stromal
demarcation line depth in group 1 was significantly deeper than in group 2.
Conclusions:
Corneal stromal demarcation line depth after a 30-minute CXL
treatment was significantly deeper than after a 10-minute CXL procedure with high
intensity UV-A irradiation. FINANCIAL INTEREST: NONE